| 前收市價 | 27.91 |
| 開市 | 26.69 |
| 買盤 | 0.00 x 0 |
| 賣出價 | 0.00 x 0 |
| 今日波幅 | 26.69 - 26.69 |
| 52 週波幅 | 25.77 - 32.43 |
| 成交量 | |
| 平均成交量 | 1,179 |
| 市值 | 16.884B |
| Beta 值 (5 年，每月) | 1.08 |
| 市盈率 (最近 12 個月) | 39.84 |
| 每股盈利 (最近 12 個月) | 0.67 |
| 業績公佈日 | 2024年5月08日 |
| 遠期股息及收益率 | 0.99 (3.26%) |
| 除息日 | 2023年5月18日 |
| 1 年預測目標價 | 8.04 |
BloombergFresenius Sells Controlling Stake in Vamed Rehab Business to PAI
(Bloomberg) -- Fresenius SE has agreed to sell a controlling stake in the rehabilitation business of its Vamed unit to French private equity firm PAI Partners as the German healthcare company further trims its portfolio.Most Read from BloombergSaudi Arabia Steps Up Arrests Of Those Attacking Israel OnlineTurkey Confirms All Trade Halt With Israel Over War in GazaHuawei Secretly Backs US Research, Awarding Millions in PrizesBiden Calls Ally Japan ‘Xenophobic’ Along With China, RussiaIn Jamie Dimo
ZacksInogen (INGN) Up 26.6% Since Last Earnings Report: Can It Continue?
Inogen (INGN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
ZacksParagon 28, Inc. (FNA) Moves 16.2% Higher: Will This Strength Last?
Paragon 28, Inc. (FNA) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
